Pharmaceutical depot comprising N-{5t (cyclopropylamino) carbonyl] - 2-methylphenyl}-3-fluoro-4- (pyridin-2-ylmethox y) benzamide

Details for Australian Patent Application No. 2009235240 (hide)

Owner AstraZeneca AB

Inventors Bateman, Nicola Frances; Nash, Ian Alun; MacFaul, Philip Alexander

Agent Freehills

Pub. Number AU-A-2009235240

PCT Pub. Number WO2009/125226

Priority 61/043,491 09.04.08 US

Filing date 9 April 2009

Wipo publication date 15 October 2009

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/125226 Priority application(s): WO2009/125226

16 December 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pharmaceutical depot comprising N- {5-[(cyclopropylamino) carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy) benzamide

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009235241-Assay device comprising bubble-forming means

2009235239-Gas sensor